Notice of Closed Meeting, 19768 [2018-09475]

Download as PDF 19768 Federal Register / Vol. 83, No. 87 / Friday, May 4, 2018 / Notices picture identification issued by a state, federal or international government. As required by the Federal Property Management Regulations, all persons entering in or on Federal controlled property and their packages, briefcases, and other containers in their immediate possession are subject to being x-rayed and inspected. Federal law prohibits the knowing possession or the causing to be present of firearms, explosives and other dangerous weapons and illegal substances. The meeting room accommodates approximately 78 people. The meeting will be held on June 19, 2018, 11:00 a.m.–5:30 p.m., EDT, and June 20, 2018, 8:30 a.m.–1:00 p.m., EDT. ADDRESSES: NCHS Headquarters, 3311 Toledo Road, Hyattsville, Maryland 20782. Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2018–09473 Filed 5–3–18; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention amozie on DSK3GDR082PROD with NOTICES VerDate Sep<11>2014 18:16 May 03, 2018 Jkt 244001 [CDC–2018–0024; Docket Number NIOSH– 302] Draft—National Occupational Research Agenda for Respiratory Health; Extension of Comment Period National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AGENCY: Charles J. Rothwell, Director, NCHS/ CDC, 3311 Toledo Road, Room 2627, Hyattsville, Maryland 20782, telephone (301) 458–4500, email cjr4@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: This committee is charged with providing advice and making recommendations to the Secretary, Department of Health and Human Services; the Director, CDC; and the Director, NCHS, regarding the scientific and technical program goals and objectives, strategies, and priorities of NCHS. Matters to be Considered: Day One meeting agenda includes: Welcome remarks by NCHS leadership; update on Selected NCHS OPIOID Related Projects; update on Health, United States 2017 and Beyond; Day Two meeting agenda includes: Update on Visualizing the National Health Interview Survey Early Release Program: A New Online Dynamic Report; and an update on National Health and Nutrition Examination Survey 2013: The Future is Now. Requests to make oral presentations should be submitted in writing to the contact person listed below. All requests must contain the name, address, telephone number, and organizational affiliation of the presenter. Written comments should not exceed five single-spaced typed pages in length and must be received by June 4, 2018. Agenda items are subject to change as priorities dictate. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and [FR Doc. 2018–09442 Filed 5–3–18; 8:45 am] BILLING CODE 4163–19–P BILLING CODE 4163–19–P DATES: FOR FURTHER INFORMATION CONTACT: Dated: April 25, 2018. Frank J. Hearl, Chief of Staff, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. Notice and extension of comment period. ACTION: On March 15, 2018 the National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), published a notice in the Federal Register [83 FR 11537] announcing the availability of a draft NORA Agenda entitled National Occupational Research Agenda for Respiratory Health for public comment. Written comments were to be received by May 14, 2018. In response to a request from an interested party, NIOSH is extending the public comment period to July 13, 2018. SUMMARY: FOR FURTHER INFORMATION CONTACT: Emily Novicki NORACoordinator@ cdc.gov), National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Mailstop E–20, 1600 Clifton Road NE, Atlanta, GA 30329, phone (404) 498– 2581 (not a toll free number). You may submit comments, identified by CDC–2018–0024 and Docket Number NIOSH–302, by either of the following two methods: • Federal eRulemaking Portal: https:// www.regulations.gov Follow the instructions for submitting comments. • Mail: National Institute for Occupational Safety and Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C–34, Cincinnati, Ohio 45226–1998. ADDRESSES: PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—Funding Opportunity Announcement (FOA), PAR 16–098, Cooperative Research Agreements to the World Trade Center Health Program (U01). Date: June 25, 2018. Times: 1:00 p.m.–4:00 p.m. EDT. Place: Teleconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Nina Turner, Ph.D., Scientific Review Officer, CDC/NIOSH, 1095 Willowdale Road, Mailstop G905, Morgantown, West Virginia 26505, Telephone: (304) 285–5975. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2018–09475 Filed 5–3–18; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\04MYN1.SGM 04MYN1

Agencies

[Federal Register Volume 83, Number 87 (Friday, May 4, 2018)]
[Notices]
[Page 19768]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-09475]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Public Law 92-463. The 
grant applications and the discussions could disclose confidential 
trade secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the grant 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: Disease, Disability, and Injury Prevention 
and Control Special Emphasis Panel (SEP)--Funding Opportunity 
Announcement (FOA), PAR 16-098, Cooperative Research Agreements to 
the World Trade Center Health Program (U01).
    Date: June 25, 2018.
    Times: 1:00 p.m.-4:00 p.m. EDT.
    Place: Teleconference.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Nina Turner, Ph.D., Scientific 
Review Officer, CDC/NIOSH, 1095 Willowdale Road, Mailstop G905, 
Morgantown, West Virginia 26505, Telephone: (304) 285-5975.

    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2018-09475 Filed 5-3-18; 8:45 am]
 BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.